| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
690 |
657 |
$71K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,031 |
993 |
$59K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
800 |
716 |
$22K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
163 |
163 |
$14K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,016 |
1,016 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
172 |
167 |
$8K |
| 96127 |
|
506 |
506 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
137 |
133 |
$4K |
| 99177 |
|
224 |
224 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
32 |
32 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
134 |
134 |
$1K |
| 0071A |
|
18 |
18 |
$825.84 |
| 92552 |
|
44 |
44 |
$717.64 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
18 |
18 |
$479.75 |
| 94760 |
|
64 |
60 |
$147.07 |